Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5

Brain

Volumn 133, Issue 3, 2010, Pages 835-846

  Black, Joel A ^a,b   Newcombe, Jia ^c   Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brain tumour; Multiple sclerosis; Reactive astrocytes; Sodium channels; Stroke

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); POTASSIUM PUMP; VOLTAGE GATED SODIUM CHANNEL;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; UPREGULATION; WHITE MATTER;

ACUTE DISEASE; ADULT; AGED; ASTROCYTES; BRAIN; BRAIN NEOPLASMS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MUSCLE PROTEINS; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; SODIUM CHANNELS; STROKE; UP-REGULATION;

EID: 77950223688     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq003     Document Type: Article

References (61)

1. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996; 379: 257-262.
2. Al-Ali SY, Al-Hussain SM. An ultrastructural study of phagocytic activity of astrocytes in adult rat brain. J Anat 1996; 188: 257-262.
3. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci 1995; 92: 12041-12045.
4. Barber MJ, Starmer CF, Grant AO. Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites. Circ Res 1991; 69: 677-696.
5. Barres BA, Chun LL, Corey DP. Glial and neuronal forms of the voltage-dependent sodium channel: characteristics and cell-type distribution. Neuron 1989; 2: 1375-1388.
6. Bechtold DA, Kapoor R, Smith KJ. Axonal protection mediated by flecai-nide therapy in experimental inflammatory demyelinating disease. J Neurol 2002; 249 (Suppl.1): S204.
7. Bechtold DA, Kapoor R, Smith KJ. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 2004; 55: 607-616.
8. Bechtold DA, Miller SJ, Dawson AC, Sun Y, Kapoor R, Berry D, et al. Axonal protection achieved in a model of multiple sclerosis using lamo-trigine. J Neurol 2006; 253: 1542-1551.
9. Bevan S, Chiu SY, Gray PT, Ritchie JM. The presence of voltage-gated sodium, potassium and chloride channels in rat cultured astrocytes. Proc R Soc Lond B Biol Sci 1985; 225: 299-313.
10. Bevan S, Lindsay RM, Perkins MN, Raff MC. Voltage-gated ionic channels in rat cultured astrocytes, reactive astrocytes and an astro-cyte-oligodendrocyte progenitor cell. J Physiol (Paris) 1987; 82: 327-335.
11. Black JA, Dib-Hajj S, Cohen S, Hinson AW, Waxman SG. Glial cells have heart: rH1 Na+ channel mRNA and protein in spinal cord astrocytes. Glia 1998; 23: 200-208.
12. Black JA, Liu S, Waxman SG. Sodium channel activity modulates multiple functions in microglia. Glia 2009; 57: 1072-1081.
13. Black JA, Newcombe J, Trapp BD, Waxman SG. Sodium channel expression within chronic multiple sclerosis plaques. J Neuropathol Exp Neurol 2007; 66: 828-837.
14. Black JA, Waxman SG. Sodium channel expression: a dynamic process in neurons and non-neuronal cells. Dev Neurosci 1996; 18: 139-152.
15. Black JA, Westenbroek R, Ransom BR, Catterall WA, Waxman SG. Type II sodium channels in spinal cord astrocytes in situ: immunocytochem-ical observations. Glia 1994a; 12: 219-227.
16. Black JA, Yokoyama S, Waxman SG, Oh Y, Zur KB, Sontheimer H, et al. Sodium channel mRNAs in cultured spinal cord astrocytes: in situ hybridization in identified cell types. Brain Res Mol Brain Res 1994b; 23: 235-245.
17. Brackenbury WJ, Chioni AM, Diss JK, Djamgoz MB. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2007; 101: 149-160.
18. Carrithers MD, Chatterjee G, Carrithers LM, Offoha R, Iheagwara U, Rahner C, et al. Regulation of podosome formation in macrophages by a splice variant of the sodium channel SCN8A. J Biol Chem 2009; 284: 8114-8126.
19. Carrithers MD, Dib-Hajj S, Carrithers LM, Tokmoulina G, Pypaert M, Jonas EA, et al. Expression of the voltage-gated sodium channel NaV1.5 in the macrophage late endosome regulates endosomal acidification. J Immunol 2007; 178: 7822-7832.
20. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005; 57: 397-409.
21. Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, Black JA, et al. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 2005; 49: 220-229.
22. Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci 2004; 101: 8168-8173.
23. Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci 1998; 95: 8963-8968.
24. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001; 36: 180-190.
25. Durelli L, Mutani R, Sechi GP, Monaco F, Glorioso N, Gusmaroli G. Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon? Arch Neurol 1985; 42: 1067-1068.
26. Hains BC, Black JA, Waxman SG. Primary motor neurons fail to up-regulate voltage-gated sodium channel Na(v)1.3/brain type III following axotomy resulting from spinal cord injury. J Neurosci Res 2002; 70: 546-552.
27. Holley JE, Gveric D, Newcombe J, Cuzner ML, Gutowski NJ. Astrocyte characterization in multiple sclerosis glial scar. Neuropathol App Neurobiol 2003; 29: 434-444.
28. Inglese M, Madelin G, Oesingmann N, Babb J, Wu W, Stoekel B, Herbert J, Johnson G. Brain tissue sodium concentration in multiple sclerosis: A 23Na-imaging study at 3 Tesla. Brain (in press).
29. Kalmar B, Kittel A, Lemmens R, Kö rnyei Zs, Madarasz E. Cultured astrocytes react to LPS with increased cyclooxygenase activity and phagocytosis. Neurochem Int 2001; 38: 453-461.
30. Kapoor R. Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design. Curr Opin Neurol 2006; 19: 255-259.
31. Kennebäck G, Bergfeldt L, Tomson T. Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjects. Cardiovasc Drugs Ther 1995; 9: 709-714.
32. Lee SC, Moore GF, Golenwsky G, Raine CS. Multiple Sclerosis: a role for astroglia in active demyelination suggested by Class II MHC expression and ultrastructure study. J Neuropath Exp Neurol 1990; 49: 122-136.
33. Lo AC, Black JA, Waxman SG. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport 2002; 13: 1909-1912.
34. Lo AC, Saab CY, Black JA, Waxman SG. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 2003; 90: 3566-3571.
35. MacFarlane SN, Sontheimer H. Spinal cord astrocytes display a switch from TTX-sensitive to TTX-resistant sodium currents after injury-induced gliosis in vitro. J Neurophysiol 1998; 79: 2222-2226.
36. Nair A, Frederick TJ, Miller SD. Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci 2008; 65: 2702-2720.
37. Newcombe J, Cuzner ML. Organization and research applications of the U.K. Multiple Sclerosis Society Tissue Bank. J Neural Transm Suppl 1993; 39: 155-163.
38. Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, Arumugam TV. Toll-like receptors in neurodegeneration. Brain Res Rev 2009; 59: 278-292.
39. Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 2003; 227: 529-537.
40. Prat A, Antel J. Pathogenesis of multiple sclerosis. Curr Opin Neurol 2005; 18: 225-230.
41. Ramos E, O'Leary ME. State-dependent trapping of flecainide in the cardiac sodium channel. J Physiol 2004; 560: 37-49.
42. Ritchie JM. Voltage-gated cation and anion channels in mammalian Schwann cells and astrocytes. J Physiol (Paris) 1987; 82: 248-257.
43. Rogart RB, Cribbs LL, Muglia LK, Kephart DD, Kaiser MW. Molecular cloning of a putative tetrodotoxin-resistant rat heart Na+ channel isoform. Proc Natl Acad Sci USA 1989; 86: 8170-8174.
44. Satin J, Kyle JW, Chen M, Rogart RB, Fozzard HA. The cloned cardiac Na channel alpha-subunit expressed in Xenopus oocytes show gating and blocking properties of native channels. J Membr Biol 1992; 130: 11-22.
45. Schaller KL, Krzemien DM, Yarowsky PJ, Krueger BK, Caldwell JH. A novel, abundant sodium channel expressed in neurons and glia. J Neurosci 1996; 15(5, Pt 1): 3231-3242.
46. Sontheimer H, Black JA, Ransom BR, Waxman SG. Ion channels in spinal cord astrocytes in vitro. I. Transient expression of high levels of Na+ and K+ channels. J Neurophysiol 1992a; 68: 985-1000.
47. Sontheimer H, Black JA, Waxman SG. Voltage-gated Na+ channels in glia: properties and possible functions. Trends Neurosci 1996; 19: 325-331.
48. Sontheimer H, Fernandez-Marques E, Ullrich N, Pappas CA, Waxman SG. Astrocyte Na+ channels are required for maintenance of Na+/K(+)-ATPase activity. J Neurosci 1994; 14(5 Pt 1): 2464-2475.
49. Sontheimer H, Minturn JE, Black JA, Ransom BR, Waxman SG. Two types of Na+-currents in cultured rat optic nerve astrocytes: changes with time in culture and with age of derivation. J Neurosci Res 1991; 30: 275-287.
50. Sontheimer H, Ransom BR, Waxman SG. Different Na+ currents in P0-and P7-derived hippocampal astrocytes in vitro: evidence for a switch in Na+ channel expression in vivo. Brain Res 1992b; 597: 24-29.
51. Sontheimer H, Waxman SG. Ion channels in spinal cord astrocytes in vitro. II. Biophysical and pharmacological analysis of two Na+ current types. J Neurophysiol 1992; 68: 1001-1011.
52. Thio CL, Sontheimer H. Differential modulation of TTX-sensitive and TTX-resistant Na+ channels in spinal cord astrocytes following activation of protein kinase C. J Neurosci 1993; 13: 4889-4897.
53. Thio CL, Waxman SG, Sontheimer H. Ion channels in spinal cord astro-cytes in vitro. III. Modulation of channel expression by coculture with neurons and neuron-conditioned medium. J Neurophysiol 1993; 69: 819-831.
54. Thulborn KR, Davis D, Snyder J, Yonas H, Kassam A. Sodium MR imaging of acute and subacute stroke for assessment of tissue viability. Neuroimaging Clin N Am 2005; 15: 639-653.
55. Toledo-Aral JJ, Moss BL, He Z-J, Koszowski AG, Whisenand T, Levinson SR, et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neruons. Proc Natl Acad Sci 1997; 94: 1527-1532.
56. Van Der Voorn P, Tekstra J, Beelen RHJ, Tensen CP, Van Der Valk P, De Groot JA. Expression of MCP-1 by reactive astrocytes in demyeli-nating multiple sclerosis lesions. Am J Pathol 1999; 154: 45-51.
57. Verkhratsky A, Steinhäuser C. Ion channels in glial cells. Brain Res Brain Res Rev 2000; 32: 380-412.
58. Vinores SA, Herman MM. Phagocytosis of myelin by astrocytes in explants of adult rabbit cerebral white matter maintained on Gelfoam matrix. J Neuroimmunol 1993; 43: 169-176.
59. Waxman SG. Mechanisms of disease: sodium channels and neuroprotec-tion in multiple sclerosis-current status. Nat Clin Pract Neurol 2008; 4: 159-169.
60. Williams A, Piaton G, Lubetzki C. Astrocytes\friends of foes in multiple sclerosis? Glia 2007; 55: 1300-1312.
61. Wu WK, Li GR, Wong HP, Hui MK, Tai EK, Lam EK, , et al. Cho CH. Involvement of Kv1.1 and Nav1.5 in proliferation of gastric epithelial cells. J Cell Physiol 2006; 207: 437-444.